QIAGEN will be at the 36th European Congress of Pathology (ECP) in Florence from September 7-11, 2024, in Florence, Italy. At the event, be sure to check out our poster […]
Using CLC Genomics Workbench, we will go through a pipeline for analyzing metatranscriptome NGS data from microbial communities and perform pathways interpretation on it. Import "raw" NGS sequencing data and […]
Neoantigens are among the newest promising targets for cancer treatment. Unlike tumor-associated antigens, neoantigens are produced only by tumor cells. These unique molecular markers are highly visible to the immune […]
Per feedback of scientists interested in taking advantage of non-oncological diseases (inflammatory, infectious, metabolic and more) as well as normal tissues (example toxicology/target safety assessment) omics, we are hosting this […]
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis […]
QIAGEN Ingenuity Pathway Analysis (IPA) is designed to help you analyze and compare different types of 'omics data. In this webinar, we’ll compare bulk RNA-seq and single-cell RNA-seq data to […]
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries […]
For RNA-seq data, you will learn how to: Import FASTQ files, cell matrix files and metadata and how to download references Map reads to a reference genome and generate gene […]
In the rapidly evolving landscape of drug discovery, the ability to integrate high-quality research findings into knowledge graphs is paramount. For over twenty years, our scientists have curated the relationships […]
Learn how QCI Interpret, clinical decision support software for variant interpretation and reporting, can help your lab rapidly identify pathogenic variants, improve diagnostic yields, and significantly reduce test turnaround time for hereditary diseases. Attendees will receive a demonstration of QCI Interpret’s unique capabilities and advanced features for germline variant interpretation with example workflows for carrier […]
Meet QIAGEN at the Variant Effect Prediction Training Course (VEPTC) This year at the 2024 Variant Effect Prediction Training Course (VEPTC), QIAGEN will be showcasing our industry-leading next-generation sequencing (NGS) variant analysis, interpretation and reporting solutions. Trusted to analyze and interpret more than 4 million NGS patient test cases, QIAGEN Clinical Insight (QCI) is the industry’s […]
In gene therapy space, there is great interest in discovering new gene editing targets as well as identifying new indications for known targets though exploration of vector biology and studying biological mechanism underlying disease pathology. In this webinar, we will focus on how recently introduced Biomedical KB-AI can enable and accelerate such investigation. QIAGEN Biomedical […]
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships […]
Watch Now
